Impressive momentum and backing! Approximately how much more in financing do you anticipate to need to get Future Cardia fully approved and sales started?

Thank you Jason for your support. We are currently raising an additional $5 million, which will enable us to file for FDA clearance and commence commercialization by mid-2025. This timeline and cost are significantly more efficient than many other implantable bioelectric startups, achieving our goals in half the time and at half the cost. Jae B

Hello Jae, would like to invest , May i use Roth Ira account Like last time ??

Hello Peter, We are thankful for your support. I believe it is possible with Wefunder as well. Feel free to proceed, and I will double check on my side as well.

Shouldn't it be called a "minimally-invasive procedure" instead of a "non-invasive procedure" when implanting the device? You state: "The non-invasive procedure is performed in-office under local anesthesia. With just one small incision, our device is implanted subcutaneously,...

Hi Dan, It is fixed. Thank you again for flagging it for us!

So when the battery runs out after two years I assume the implant device has to be removed to replace the battery and then reinserted back into the body. Correct?

Hi Dan, Yes. correct. our implant and explant procedures are the same as the rest. Jae b

Hi Jaeson, are you aware of Ilika's "Stereax Solid State Batteries"? These may be of interest as your product seems to require safe, long lasting batteries. : https://www.ilika.com/micro-solid-state-batteries Ilika is a listed co. Regards.

Hi Dion, We love Solid State Batteries, however, they are not ready for the prime time... And we know iLika well. However, Those are at the experimental stage and not ready for the prime time yet.

Future Cardia

YC Dropout raises $14M to take on the $110B market w/ AI-powered implantable devices

https://wefunder.com/futurecardia

Total raised on Wefunder: 1724955

Total investors: 1190

Quick facts

5x Top 10 "Most Raised Reg-CF" NATIONWIDE, 10x "Most Raised" on Wefunder & Kingscrowd "Top Deal"
Incubated by Johnson & Johnson JLABS, accelerated by Stanford’s StartX
Backed by Sand Hill Angels (SweetGarden, Ro, Masterclass, Parsley Health and many other major exits)
Multiple exits & two IPOs achieved by team of experts from Medtronic, Boston Scientific, Stanford
39 devices implanted at world-renowned medical centers & 70,000+ hours of cardiac data collected
Limited players, premium pricing, a high value to patients & physicians with simplicity and accuracy
$110B implantable medical device market
Forecasting $40M+ in revenue within five years (not guaranteed)

Investor memo sources

Sixto Global Capital, LLC: https://uploads.wefunder.com/uploads/remote_files/889984-1Q9TWw2kZBdsKQkpWNzQ5RhZ/Future_Cardia_Investment_Memo_-_Dec_2024.docx.pdf (not paid for by company)
Kingscrowd Capital: https://wefunder.com/updates/176834 (not paid for by company)

Team profiles

Jaeson Bang

Featured investor profiles

Future Cardia

YC Dropout raises $14M to take on the $110B market w/ AI-powered implantable devices

futurecardia.com

Tampa, FL

Technology Notable Angel B2B Healthcare SaaS

What Investors Say

Manager Sixto Global Capital

LEAD INVESTOR

Invested $75,000 this round + $1,500,000 previously

Heart failure affects over 6 million patients in the US alone, leading to over 1 million hospitalizations annually, making it one of the most costly healthcare burdens at $40 billion per year. Similar challenges are observed in Canada and the EU.
Patients and physicians often find themselves in a dilemma: whether to rush to the emergency room or wait it out.
Consequently, many end up in the ER, even when it's a false alarm.
Future Cardia employs a subcutaneous monitoring approach, tracking ECG and heart sounds as biomarkers for continuous cardiac function assessment. By monitoring trends, they gather quantifiable data, enabling proactive interventions to prevent heart failure decompensation events before they occur. At Sixto Global Capital, we believe this technology will truly be a game changer in cardiac care.

What People Say

Future Cardia

Quick facts

Investor memo sources

Team profiles

Featured investor profiles

$5,453,835

What Investors Say